Attention To Details: Neos' ADHD Portfolio By: Benzinga via Benzinga June 26, 2017 at 09:05 AM EDT Neos Therapeutics Inc (NASDAQ: NEOS) shares began tumbling on June 21, despite announcing late on June 20 that the FDA approved its ... Read More >> Related Stocks: Bank of Montreal Eli Lilly Johnson & Johnson Neos Therapeutics Novan Inc Novartis Ag ADR Pfizer Shire Plc Ads